Pharmaceutical manufacturing facility with workers and machinery
India’s pharmaceutical market is on track to maintain its robust double-digit growth trajectory, according to a recent analysis by Equirus. The market demonstrated strong performance in May, with demand across all therapeutic segments showing significant uplift.
A key driver of this expansion is the sustained momentum in chronic therapies, which continue to lead market growth. Alongside this, acute therapies have also exhibited notable improvement, contributing to the overall positive trend. Equirus highlights that accelerating volume growth is a critical factor, indicating increased product uptake and market penetration.
Furthermore, the introduction of new drugs is playing a significant role in bolstering market performance. This broad-based demand across different therapeutic areas suggests a healthy and expanding market, with expectations for continued expansion in the coming months. The report underscores the resilience and growth potential within the Indian pharmaceutical sector.
About the Author
